Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IMMX | US
0.25
17.36%
Healthcare
Biotechnology
30/06/2024
17/10/2024
1.69
1.46
1.99
1.46
Immix Biopharma Inc. a clinical-stage biopharmaceutical company engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111 a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120 a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles California.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
144.8%1 month
102.9%3 months
78.0%6 months
88.4%-
-
1.56
0.05
0.04
-0.37
-
-
-20.18M
46.39M
46.39M
-
-
-
-
-103.81
6.35
6.44
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.73
Range1M
0.73
Range3M
1.18
Rel. volume
2.37
Price X volume
648.12K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Fortress Biotech Inc | FBIO | Biotechnology | 1.81 | 49.89M | 3.43% | n/a | 494.61% |
CollPlant Holdings Ltd | CLGN | Biotechnology | 4.28 | 49.03M | -5.10% | n/a | 0.00% |
Rafael Holdings Inc | RFL | Biotechnology | 1.97 | 48.40M | -3.90% | n/a | 2.77% |
Anebulo Pharmaceuticals Inc. Common Stock | ANEB | Biotechnology | 1.83 | 47.46M | -3.17% | n/a | 0.00% |
Rallybio Corporation Common Stock | RLYB | Biotechnology | 1.09 | 45.22M | -0.46% | n/a | 0.35% |
Lexaria Bioscience Corp | LEXX | Biotechnology | 2.83 | 44.74M | -1.39% | n/a | 1.41% |
Eyenovia Inc | EYEN | Biotechnology | 0.508 | 43.49M | -7.64% | n/a | -662.22% |
LAVA Therapeutics BV | LVTX | Biotechnology | 1.65 | 43.39M | 0.00% | n/a | 14.37% |
CALC | CALC | Biotechnology | 3.9595 | 42.57M | -4.36% | n/a | 0.00% |
Clene Nanomedicine Inc | CLNN | Biotechnology | 5.34 | 42.52M | -5.82% | n/a | -6472.02% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.37 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 1.56 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 78.01 | 72.92 | Par |
Debt to Equity | 0.05 | -1.24 | Expensive |
Debt to Assets | 0.04 | 0.25 | Cheaper |
Market Cap | 46.39M | 3.78B | Emerging |